In Brief: FDA Obstetrics and Gynecology Devices Panel
This article was originally published in The Gray Sheet
Executive Summary
FDA Obstetrics and Gynecology Devices Panel: Meeting Feb. 26 at 8:30 a.m. at the Center for Devices and Radiological Health, 9200 Corporate Blvd., Rockville, Maryland, to discuss "general issues relating to a premarket approval application for a tubal occlusion device for female sterilization," according to a Feb. 8 Federal Register notice. The committee also will be presented with data from the Centers for Disease Control and Prevention on the U.S. Collaborative Review of Sterilization ("CREST") study. For information contact FDA's Alfred Montgomery at 301/594-1180...